Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancer Medicine|December 27, 2022
Oncology distress screening within predominately Black Veterans: Outcomes on supportive care utilization, hospitalizations, and mortalityDesiree R Azizoddin, Matthew Allsop, Subrina Farah, et al.
The American Journal of Emergency Medicine|July 28, 2023
Extraglottic device use is rare during emergency airway management: A National Emergency Airway Registry (NEAR) studyMichael D April, Brian Driver, Steven G Schauer, et al.
AJR. American Journal of Roentgenology|August 31, 2022
Utility of Normalized Body Composition Areas, Derived From Outpatient Abdominal CT Using a Fully Automated Deep Learning Method, for Predicting Subsequent Cardiovascular EventsKirti Magudia, Christopher P Bridge, Camden P Bay, et al.
Applied Clinical Informatics|April 18, 2024
Looking Beyond Mortality Prediction: Primary Care Physician Views of Patients' Palliative Care Needs Predicted by a Machine Learning ToolLisa Rotenstein, Liqin Wang, Sophia N Zupanc, et al.
Journal of the Endocrine Society|July 6, 2026
The impact of statins on aldosterone production in healthy adults: a randomized controlled studyYan Emily Yuan, Lindsey M Porter, Andrea V Haas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2021
Biomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR TrialThomas Denize, Subrina Farah, Alessia Cimadamore, et al.
Journal of General Internal Medicine|June 27, 2019
"Get Ready and Empowered About Treatment" (GREAT) Study: a Pragmatic Randomized Controlled Trial of Activation in Persons Living with HIVJennifer K Carroll, Jonathan N Tobin, Amneris Luque, et al.
BMC Public Health|October 18, 2015
Activation of persons living with HIV for treatment, the great studyKevin Fiscella, Michele Boyd, Julian Brown, et al.
Cancer|November 20, 2020
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignanciesBradley Alexander McGregor, Matthew T Campbell, Wanling Xie, et al.
JCO Precision Oncology|February 16, 2022
Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell CarcinomaBradley A McGregor, Wanling Xie, Elio Adib, et al.
Pageof 3